Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - G1 Therapeutics, Inc. | gthx-ex322_7.htm |
| EX-32.1 - EX-32.1 - G1 Therapeutics, Inc. | gthx-ex321_6.htm |
| EX-31.2 - EX-31.2 - G1 Therapeutics, Inc. | gthx-ex312_9.htm |
| EX-31.1 - EX-31.1 - G1 Therapeutics, Inc. | gthx-ex311_10.htm |
| EX-4.2 - EX-4.2 - G1 Therapeutics, Inc. | gthx-ex42_212.htm |
| 10-K - GTHX-10K-2019 - G1 Therapeutics, Inc. | gthx-10k_20191231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-236229, 333-232106, 333-226701, and 333-218468) and Form S-3 (No. 333-225678) of G1 Therapeutics, Inc. of our report dated February 26, 2020 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Raleigh, North Carolina
February 26, 2020